Significant advancements like spectral flow cytometry and high-throughput systems are boosting adoption in fields like ...
2d
Cytek Biosciences, Inc.: Cytek Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc.
(Nasdaq: CTKB) today announced its inclusion on TIME’s 2026 list of America’s Growth Leaders. Presented in partnership with global data firm Statista, the inaugural ranking recognizes the ...
(Nasdaq: CTKB) announced today that its Cytek ® Muse ® Micro cell analyzer has been named Drug Discovery Solution of the Year in the 2025 BioTech Breakthrough Awards. The annual program, conducted by ...
FREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc. ...
Immunotherapy is currently effective in less than half of patients with solid tumors, and most responders develop secondary progression. High infiltration of the tumor microenvironment (TME) with CD8 ...
A 24-parameter spectral flow cytometry panel was developed to monitor immune receptor expression in MS patients, aiding personalized treatment approaches. The panel detects 12 treatment-associated ...
Enabling clinicians to stay in flow-anytime, anywhere-with an intelligent, cloud-powered Enterprise Imaging Platform that is streaming-enabled, deeply integrated, and tailored to your workspace.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback